Food for thought: clinical research is hard. It’s hard for investigators to anticipate the “right” question often yrs in advance, & it’s difficult & often $$ for pts to participate. Over 10 yrs and nearly 1,400 pts in, the data show a consistent picture re adjuvant EGFR TKIs 1/3
The DFS benefit is significant. FDA has approved osi here. Yes, there is room for debate. Yes, will be good to see OS. Each onc can prescribe or not - your choice - but pts deserve discourse; a respectful and dignified discourse about whether this rx may be right for them 2/3
I am saddened by the ongoing bullying on #MedTwitter about this topic, consistently x 6 mo now. Opinions = welcome. Bullying = just stop. No trial is perfect. All trials represent hard work and dedication. We are all on the same team. 3/3
You can follow @LeciaSequist.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.